The action by US regulators in cartel pricing of generics by SUn, Lupin, Taro, and other generic manufacturers can be a big negative on this stock. Will need to keep a tab. Else Sun is poised to move to levels of 900 and above soon. The new buyback price is encouraging.
4.53 PM Sep 14th
a message on this stock. Hope you find this useful."2nd qr results is undoubtedly brilliant. Sun also announced termination sun-taro final deal. In this event either sun may move upward above 770 or it can also go below 720. Prmnt investers are advised to get prepared for both
11.39 AM Feb 11th 2013
IIFL Institutional Equities recommends “Buy” Sun Pharma. IIFL Institutional Equities report: Sun Pharma reported another strong quarter with revenue and Ebitda beating our estimates by 7% and 21% respectively. The upside came from continued strength from the Taro subsidiary in the US and strong
10.51 AM Feb 11th 2013
2nd qr results is undoubtedly brilliant. Sun also announced termination sun-taro final deal. In this event either sun may move upward above 770 or it can also go below 720. Prmnt investers are advised to get prepared for both. If sun goes above 770, then all the possibilities to further move above
11.45 AM Feb 10th 2013
Rs.3000 Cr. saved by not acquiring residual stake in Taro will be utilized to takeover another Co. like Taro and turn it profitable.Very good decision by visionary management. Soon this will reflect in stock price, hope it will cross Rs.800 in time to come.
7.33 PM Feb 9th 2013
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.